Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
发布时间: 2018 - 03 - 07
点击次数: 0
Positions: Senior Directo\Johnson & Johnson Innovation Center Asia-Pacific
Company: Johnson & Johnson Innovation Center Asia-Pacific
个人简介:
Dr. Mingde Xia is currently a Senior Director of Johnson & Johnson Innovation Center AP. He focuses on business partnership in mainland China, Hong Kong, and Taiwan, etc. with universities, institutes, investors and innovative companies for J & J worldwide pharmaceuticals, medical device / diagnostic products and OTC / consumer business, through investment, incubation, co-development, license and other collaboration vehicles. He has been working with Johnson & Johnson for 18 years after career track at China Pharmaceutical University and Yale University, and has successfully led / executed over 50 projects external collaboration for Johnson & Johnson three sectors. He is a guest / adjunct professor at the Chinese Academy of Sciences, a major inventor / author of over 60 patents / publications, a reviewer for a number of top quality international scientific journals, and an invited speaker for many international pharmaceutical conferences / forums. He received awards from American Chemical Society, Johnson & Johnson and different universities. He has actively involved in Sino-American Pharmaceutical Professionals Association (SAPA President 2009, Board of Directors 2008-2018) and organized many international conferences in USA and Asia.
发布时间: 2018 - 03 - 07
点击次数: 0
Positions: Co-founder and Chairman
Company: Veritas Genetics Inc
个人简介:
Dr. Yining Zhao is currently a Venture Partner at Lilly Asia Ventures (LAV) responsible for cross-board investment between US and China. He has co-founded and become CEO for several US-China biotech companies such as Just Biotherapeutics, Veritas Genetics, and NuBiyota China Inc. etc, which are focused on precision medicine.  Prior to his entrepreneurial career, Dr. Zhao has worked in the areas of Strategy Management and Business Development at multinational biopharmaceutical companies for 20 years. He was Executive Strategy Director at Global Commercial Operations of Amgen based in Thousand Oaks, California. Before that he was the Asia Strategy Lead at Pfizer based in New York.Dr. Zhao received his B.S. in Pharmaceutical Sciences from Fudan University (Shanghai, China), Ph.D. in Analytical Chemistry from Ghent University (Ghent, Belgium), and MBA from Massachusetts Institute of Technology (Cambridge, USA). He has contributed more than 30 peer-reviewed publications and book chapters.
发布时间: 2018 - 03 - 07
点击次数: 0
Positions: Board Chairman and CEO
Company: QIAGEN (Suzhou) Translational Medicine Co., Ltd
个人简介:
With over 25 years of drug R&D experience and years of experience in translational and diagnostics, Nick is now the board chairman and CEO for QIAGEN (Suzhou) Translational Medicine Co. Ltd. that provides an integrated technology platform for biomarker, companion diagnostics development and clinical testing for precision medicine. Nick was China GM and Corporate SVP for Frontage Lab, a CRO for CMC, Clinical and Bioanalytical services. Before that, Nick was a founding director and executive for Novartis China R&D center and responsible for building up CPP/TRD division in China. He also served on the cFDA Working Committee and as a reviewer for China Thousand Talents Program. Prior to Novartis, Nick was a director at US OSI Pharmaceuticals.Nick started his drug industry career at Pfizer global R&D center after he got his Ph.D degree from University of Cincinnati. During his ten years at Pfizer, he led teams at both Early and Full Development in Pharmaceutical Science, filed 5 INDs/IMPD and 1 NDA/MAA for various dosage forms. Nick represented Pfizer serving on the PRQI working committee (formed among FDA, industry and academia). Before going to US, Nick worked and studied at Chinese Academy of Sciences.Nick is now a member of Bayhelix, a global association of Chinese Life Science Business Executives; a council member of Jiangsu Life Science and Technology Association; and a director of Biomedical Committee (SEBMC), Sino-EU Chemical/Manufacturer Association.He is also one of the 2015 Suzhou SIP Leading Talents and one of 2016 Jiangsu Province Leading talent.  He is one of 5 founders for China Companion Diagnostics Consortium (in Prep)